ASTON Sci.
Latest round
- Series D
Last raised
- Aug 2026
Total raised
- $69M
Investors
- 18
About ASTON Sci.
Founded in 2018, and based in Seoul, South Korea, ASTON Sci. Inc. operates as a biopharmaceutical company that develops oncology, immunology, and geriatrics-related medicines. The company was founded by its Chief Executive Officer Hun Jung, Chief Executive Officer and Chief Business Officer Harry Hunwoo Shin, Jihyun Kim, Cwangkwang Chung, and Ilboo Kim. In August 2026, ASTON Sci. Inc. ASTON Sci conducts research, performs clinical development, and creates therapeutic medicine and vaccines for treating cancer. The company has ten clinical and preclinical pathways as of 2022, including two cancer therapeutic vaccines known as AST-301 and AST-021p. The Ministry of Food and Drug Safety is reviewing AST-301 for clinical trials, while AST-021p is in phase 1 clinical trial for advanced solid tumors. By 2030, the company plans to extend its pipeline to 15 medications across four therapeutic domains, focusing on the efficient development of novel drugs with high unmet medical needs and clinical demand. By early 2023, the company also intends to list on the KOSDAQ in order to assist its clinical and business development.
Who invested in ASTON Sci.
18 investors across 4 rounds
See all investors in ASTON Sci.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ASTON Sci.
Who invested in ASTON Sci.?
ASTON Sci. has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ASTON Sci. raised?
ASTON Sci. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did ASTON Sci. last raise money?
ASTON Sci.'s most recent round on record is a Series D, in Aug 2026.
What does ASTON Sci. do?
Founded in 2018, and based in Seoul, South Korea, ASTON Sci.
Where is ASTON Sci. headquartered?
ASTON Sci. is headquartered in Hanam, South Korea.
Which VCs invest in companies like ASTON Sci.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ASTON Sci.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like ASTON Sci.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.